SXI — what changed in the latest 10-Q
A section-by-section comparison of SXI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-10-30 vs the prior 10-Q · 2026-05-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +36 | −52 | ~16 | 22 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~5 | 2 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Other information | Text added/removed | +3 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-10-30
On July 2, 2026, we acquired the remaining 9.9% interest in India-based Narayan Powertech (Narayan), a leading manufacturer of low voltage and medium voltage instrument transformers.
Net sales increased in the first quarter of fiscal year 2027 by $15.1 million or 7.0%, as compared to the prior year quarter. Organic sales increased by $26.9 million, or 12.4%, primarily due to increased sales into fast growth markets and contributions from new products. Divestitures reduced sales …
Gross profit in the first quarter of fiscal year 2027 increased to $103.2 million, or a gross margin of 44.4%, as compared to $90.4 million, or a gross margin of 41.6%, in the first quarter of fiscal year 2026. The margin increase was a result of the continued focus on pricing disciplines and produc…
Selling, General, and Administrative (“SG&A”) expenses for the first quarter of fiscal year 2027 increased to $60.5 million, or 26.0% of sales as compared to $54.4 million, or 25.0% of sales during the prior year quarter. SG&A expenses during the first quarter of fiscal year 2027 were primarily impa…
We incurred restructuring expenses of $1.0 million in the first quarter of fiscal year 2027, primarily related to continuation of facility rationalization. We expect to continue seeing realization of these restructuring actions during the fiscal year 2027.
Text removed vs the prior filing · source: 10-Q · 2026-05-06
On March 9, 2026, we completed the divestiture of Federal Industries to a third party for cash proceeds of $68.3 million. The divestiture supports continued portfolio simplification and enables us to focus on larger businesses and fast growth end market opportunities. Post the divestiture, the Hydra…
Net sales increased in the third quarter of fiscal year 2026 by $16.8 million or 8.1%, when compared to the prior year quarter. Acquisitions accounted for increased sales of $3.3 million or 1.6%. Divestitures reduced sales by $2.9 million, or 1.4%. Foreign currency positively impacted sales by $2.9 …
Net sales increased in the nine months ended March 31, 2026 by $95.3 million or 16.8%, when compared to the prior year period. Acquisitions accounted for increased sales of $66.9 million or 11.8%, while divestitures reduced sales by $3.0 million or 0.5%. Foreign currency positively impacted sales by…
Gross profit in the third quarter of fiscal year 2026 increased to $91.9 million, or a gross margin of 40.9%, as compared to $82.4 million, or a gross margin of 39.7%, in the third quarter of fiscal year 2025. The margin increase was a result of the continued focus on pricing disciplines and product…
Gross profit in the nine months ended March 31, 2026 increased to $274.6 million, or a gross margin of 41.4% as compared to $224.0 million, or a gross margin of 39.4%, in the prior year period. The margin increase was a result of the continued focus on pricing disciplines and productivity actions.
Other information
Text added vs the prior filing · source: 10-Q · 2026-10-30
AGGREGATE NUMBER OF SHARES OF COMMON STOCK TO BE PURCHASED OR SOLD
Sales are to be made commencing January 4, 2027, in eleven equal monthly tranches of 40 shares, subject to a $300 per-share limit price.
(1) The plan terminates on the earliest to occur of (i) November 5, 2027, (ii) execution of all trades or expiration of all orders relating to such trades, or (iii) certain other termination events specified in the plan.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice